MBX2329
Based on 1 Customer Validation
MBX2329, a potent influenza virus inhibitor, specifically inhibits hemagglutinin (HA)-mediated viral entry with HIV/HA(H5) displaying IC90 of 8.6 μM. MBX2329 inhibits a wide spectrum of influenza A viruses, which includes the 2009 pandemic influenza virus A/H1N1/2009, highly pathogenic avian influenza (HPAI) virus A/H5N1, and oseltamivir-resistant A/H1N1 strains.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 99.90%
- No. CAS: 1438272-42-4
- Fòrmula: C16H26ClNO
- Peso molecular:283.84
-
Almacenamiento:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
-
Solvente y solubilidad
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-131059
CBS1117H1N1 Inhibitor -
HY-14818
Laninamivir -
HY-101950
KIN1148IRF3 Agonist -
HY-N0862
HarringtonineInfluenza Virus Inhibitor -
HY-107201
β-CyclodextrinInfluenza Virus Inhibitor -
HY-109025
Baloxavir marboxilInfluenza A/B Inhibitor -
HY-17016
Oseltamivir phosphateInfluenza A/B Inhibitor -
HY-109025A
BaloxavirCap-Endonuclease Inhibitor -
HY-14818R
Laninamivir (Standard) -
HY-N0440
GermacroneAnti-viral/Cancer/Inflammatory Agent -
HY-14904A
Umifenovir hydrochlorideAntiviral Agent -
HY-13317
OseltamivirInfluenza Virus Inhibitor
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDCK | CC50 |
11 μM
Compound: 14a
|
Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs by MTS assay
Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs by MTS assay
|
[PMID: 29220568] |
Chemical Information
-
No. CAS 1438272-42-4
-
Appearance Solid
-
Peso molecular 283.84
-
Fòrmula C16H26ClNO
-
Color White to off-white
-
SMILES
CCC1=CC=CC=C1OCCN2CCCCCC2.[H]Cl
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvente y solubilidad
In Vitro:
DMSO : 250 mg/mL (880.78 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (7.33 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (7.33 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (272 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.5231 mL | 17.6156 mL | 35.2311 mL | 88.0778 mL |
| 5 mM | 0.7046 mL | 3.5231 mL | 7.0462 mL | 17.6156 mL | |
| 10 mM | 0.3523 mL | 1.7616 mL | 3.5231 mL | 8.8078 mL | |
| 15 mM | 0.2349 mL | 1.1744 mL | 2.3487 mL | 5.8719 mL | |
| 20 mM | 0.1762 mL | 0.8808 mL | 1.7616 mL | 4.4039 mL | |
| 25 mM | 0.1409 mL | 0.7046 mL | 1.4092 mL | 3.5231 mL | |
| 30 mM | 0.1174 mL | 0.5872 mL | 1.1744 mL | 2.9359 mL | |
| 40 mM | 0.0881 mL | 0.4404 mL | 0.8808 mL | 2.2019 mL | |
| 50 mM | 0.0705 mL | 0.3523 mL | 0.7046 mL | 1.7616 mL | |
| 60 mM | 0.0587 mL | 0.2936 mL | 0.5872 mL | 1.4680 mL | |
| 80 mM | 0.0440 mL | 0.2202 mL | 0.4404 mL | 1.1010 mL | |
| 100 mM | 0.0352 mL | 0.1762 mL | 0.3523 mL | 0.8808 mL |
MBX2329 Related Classifications
HY-131069A Related Classifications
Powered by Bioz